XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Paid-in Capital
Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Treasury Stock
Nonredeemable Noncontrolling Interests
Beginning balance (in shares) at Jan. 29, 2022     62,697,032              
Beginning balance at Jan. 29, 2022 $ 653,643 $ (21,723) $ 627 $ 565,024 $ (43,078) $ 1,158,664 $ 21,355 $ (135,549) $ (966,108) $ 30,985
Beginning balance (in shares) at Jan. 29, 2022                 80,074,914  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings 10,454         7,970       2,484
Other comprehensive income (loss), net of income tax (11,640)             (11,164)   (476)
Issuance of common stock under stock compensation plans (in shares)     411,785           411,785  
Issuance of common stock under stock compensation plans 1,470   $ 4 (3,608)         $ 5,074  
Issuance of stock under Employee Stock Purchase Plan (in shares)     10,976           10,976  
Issuance of stock under Employee Stock Purchase Plan 206     69         $ 137  
Share-based compensation 4,052     4,003   49        
Dividends, net of forfeitures on non-participating securities (13,659)         (13,659)        
Share repurchases (in shares)     (3,789,576)           (3,789,576)  
Share repurchases (81,747)   $ (38) 38         $ (81,747)  
Noncontrolling interest capital distribution (4,817)                 (4,817)
Equity forward contract issuance (105,000)     (105,000)            
Ending balance (in shares) at Apr. 30, 2022     59,330,217              
Ending balance at Apr. 30, 2022 431,239 433 $ 593 417,448   1,174,379 433 (146,713) $ (1,042,644) 28,176
Ending balance (in shares) at Apr. 30, 2022                 83,441,729  
Beginning balance (in shares) at Jan. 29, 2022     62,697,032              
Beginning balance at Jan. 29, 2022 653,643 (21,723) $ 627 565,024 $ (43,078) 1,158,664 21,355 (135,549) $ (966,108) 30,985
Beginning balance (in shares) at Jan. 29, 2022                 80,074,914  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings 37,894                  
Other comprehensive income (loss), net of income tax               (20,975)    
Ending balance (in shares) at Jul. 30, 2022     54,437,964              
Ending balance at Jul. 30, 2022 442,173   $ 544 525,776   1,184,896   (156,524) $ (1,143,849) 31,330
Ending balance (in shares) at Jul. 30, 2022                 88,333,982  
Beginning balance (in shares) at Apr. 30, 2022     59,330,217              
Beginning balance at Apr. 30, 2022 431,239 $ 433 $ 593 417,448   1,174,379 $ 433 (146,713) $ (1,042,644) 28,176
Beginning balance (in shares) at Apr. 30, 2022                 83,441,729  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings 27,440         23,962       3,478
Other comprehensive income (loss), net of income tax (10,135)             (9,811)   (324)
Issuance of common stock under stock compensation plans (in shares)     290,393           290,393  
Issuance of common stock under stock compensation plans 239   $ 3 (3,392)         $ 3,628  
Issuance of stock under Employee Stock Purchase Plan (in shares)     13,381           13,381  
Issuance of stock under Employee Stock Purchase Plan 211     44         $ 167  
Share-based compensation 6,627     6,624   3        
Dividends, net of forfeitures on non-participating securities (13,881)         (13,881)        
Share repurchases (in shares)     (5,196,027)           (5,196,027)  
Share repurchases (105,000)   $ (52) 52         $ (105,000)  
Equity forward contract settlement 105,000     105,000            
Ending balance (in shares) at Jul. 30, 2022     54,437,964              
Ending balance at Jul. 30, 2022 $ 442,173   $ 544 525,776   1,184,896   (156,524) $ (1,143,849) 31,330
Ending balance (in shares) at Jul. 30, 2022                 88,333,982  
Beginning balance (in shares) at Jan. 28, 2023 54,609,786   54,609,786              
Beginning balance at Jan. 28, 2023 $ 572,751   $ 546 532,398   1,276,857   (134,073) $ (1,141,615) 38,638
Beginning balance (in shares) at Jan. 28, 2023 88,161,467               88,161,467  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings $ (10,694)         (11,805)       1,111
Other comprehensive income (loss), net of income tax (4,095)             (5,404)   1,309
Issuance of common stock under stock compensation plans (in shares)     1,085,319           1,085,319  
Issuance of common stock under stock compensation plans (450)   $ 11 (14,519)         $ 14,058  
Issuance of stock under Employee Stock Purchase Plan (in shares)     11,848           11,848  
Issuance of stock under Employee Stock Purchase Plan 181     28         $ 153  
Share-based compensation 4,620     4,617   3        
Dividends, net of forfeitures on non-participating securities (12,662)         (12,662)        
Share repurchases (in shares)     (2,237,872)           (2,237,872)  
Share repurchases (42,821)   $ (22) 22         $ (42,821)  
Equity component value of convertible notes transactions, net (744)     (744)            
Sale of common stock warrant 20,158     20,158            
Purchase of convertible note hedge (39,397)     (39,397)            
Termination of common stock warrant (1,024)     (1,024)            
Termination of convertible note hedge 7,235     7,235            
Ending balance (in shares) at Apr. 29, 2023     53,469,081              
Ending balance at Apr. 29, 2023 $ 493,058   $ 535 508,774   1,252,393   (139,477) $ (1,170,225) 41,058
Ending balance (in shares) at Apr. 29, 2023                 89,302,172  
Beginning balance (in shares) at Jan. 28, 2023 54,609,786   54,609,786              
Beginning balance at Jan. 28, 2023 $ 572,751   $ 546 532,398   1,276,857   (134,073) $ (1,141,615) 38,638
Beginning balance (in shares) at Jan. 28, 2023 88,161,467               88,161,467  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings $ 31,268                  
Other comprehensive income (loss), net of income tax               1,516    
Ending balance (in shares) at Jul. 29, 2023 53,587,282   53,587,282              
Ending balance at Jul. 29, 2023 $ 533,821   $ 536 514,760   1,274,835   (132,557) $ (1,168,677) 44,924
Ending balance (in shares) at Jul. 29, 2023 89,183,971               89,183,971  
Beginning balance (in shares) at Apr. 29, 2023     53,469,081              
Beginning balance at Apr. 29, 2023 $ 493,058   $ 535 508,774   1,252,393   (139,477) $ (1,170,225) 41,058
Beginning balance (in shares) at Apr. 29, 2023                 89,302,172  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net earnings 41,962         39,033       2,929
Other comprehensive income (loss), net of income tax 9,302             6,920   2,382
Issuance of common stock under stock compensation plans (in shares)     107,116           107,116  
Issuance of common stock under stock compensation plans 592   $ 1 (811)         $ 1,402  
Issuance of stock under Employee Stock Purchase Plan (in shares)     11,085           11,085  
Issuance of stock under Employee Stock Purchase Plan 170     24         $ 146  
Share-based compensation 5,455     5,455            
Dividends, net of forfeitures on non-participating securities (16,591)         (16,591)        
Purchase of redeemable noncontrolling interest 95     1,318           (1,223)
Noncontrolling interest capital distribution $ (222)                 (222)
Ending balance (in shares) at Jul. 29, 2023 53,587,282   53,587,282              
Ending balance at Jul. 29, 2023 $ 533,821   $ 536 $ 514,760   $ 1,274,835   $ (132,557) $ (1,168,677) $ 44,924
Ending balance (in shares) at Jul. 29, 2023 89,183,971               89,183,971